SCHEMBL1633064

SCHEMBL1633064

NS(=O)(=O)c1ccc(Nc2ncc3ccc(C(=O)N4CCCC4)cc3n2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MTOR P42345 1/20 0.62
▸ SMG1 Q96Q15 1/20 0.62
▸ CDK2 P24941 9/20 0.58
▸ CCNE1 P24864 5/20 0.58
▸ CA1 P00915 5/20 0.53
▸ CA2 P00918 5/20 0.53
▸ CA9 Q16790 5/20 0.53
▸ CA12 O43570 4/20 0.53
▸ CA7 P43166 3/20 0.53
▸ CA14 Q9ULX7 2/20 0.53
▸ ALDH1A1 P00352 1/20 0.52
▸ HPGD P15428 1/20 0.51
▸ CDK1 P06493 1/20 0.49
▸ CDK9 P50750 1/20 0.49
▸ CCNK O75909 3/20 0.47
▸ CCNA2 P20248 3/20 0.47
▸ CDK7 P50613 3/20 0.47
▸ CCNH P51946 3/20 0.47
▸ MNAT1 P51948 3/20 0.47
▸ CDK12 Q9NYV4 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3502719 0.92 MTOR (0.62) MTORSMG1CDK2CCNE1CA1
SCHEMBL1632195 0.91 CDK2 (0.56) MTORSMG1CDK2CCNE1CA1
SCHEMBL1632895 0.89 CDK2 (0.53) MTORSMG1CDK2CCNE1CA1
SCHEMBL1631321 0.85 CDK2 (0.50) MTORSMG1CDK2CCNE1CA1
SCHEMBL1633843 0.84 MAPK10 (0.54) MTORSMG1CDK2CCNE1CA1
SCHEMBL1632704 0.84 CDK2 (0.50) CDK2CCNE1CA1CA2CA9
SCHEMBL1633518 0.84 SYK (0.53) CDK2CCNE1CA1CA2CA9
SCHEMBL1869926 0.83 MTOR (0.52) MTORSMG1CDK2CCNE1CA1
SCHEMBL1570959 0.81 CDK2 (0.50) CDK2CCNE1CA1CA2CA9
SCHEMBL1633839 0.81 CDK2 (0.52) CDK2CCNE1CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 — — US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 — — US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 — — US disclosed
Send feedback